From Name:
From Email:
To Name:
To Email:

Optional Message:

Avoiding Being Hyper About Hypersensitivity: Management of Aspirin and P2Y12 Allergic Reactions

from By Craig J. Beavers, PharmD, FAHA, AACC, BCPS-AQ Cardiology, CACP; and Jayant Bagai, MD, FACC, FSCAI

Patients undergoing percutaneous coronary intervention (PCI) may report hypersensitivity reactions to aspirin or P2Y12 inhibitors in the dual antiplatelet therapy (DAPT) regimen. Care coordination amongst the team is critical for success and best outcomes for these patients. Learn evidence-based strategies, including desensitization protocols, to manage patients with hypersensitivity to either component of DAPT in this tip-of-the-month.


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063